EchoSolv AS vs Viz RV/LV

EchoSolv AS is designed for seamless integration into existing PACS workflows without requiring EMR integration, offering ultra-fast risk detection. However, Viz RV/LV, as part of the broader Viz PE Solution, provides a more comprehensive user experience with AI-powered alerts, a high-fidelity mobile DICOM image viewer, and a HIPAA-compliant communication platform for enhanced care coordination. Viz.ai also received high ratings for user satisfaction and ease of adoption in a Black Book survey.

Both tools are FDA-cleared and offer significant clinical value in their respective domains. EchoSolv AS demonstrates near-perfect accuracy in detecting severe aortic stenosis, outperforming traditional interpretation and improving gender equity in diagnosis. Viz RV/LV provides rapid and accurate automated RV/LV ratio measurements from CTPA scans, which is crucial for timely pulmonary embolism risk stratification and care coordination in acute settings.

Neither tool has publicly available pricing information. EchoSolv AS operates on a subscription-based model tied to echocardiogram volume, with current reimbursement under a miscellaneous CPT code being sporadic. Viz RV/LV, as part of the Viz Platform, has demonstrated quantifiable value through accelerated diagnosis, improved patient outcomes, reduced length of stay, and received a #1 ranking for 'Return on Technology Investment' in a Black Book survey, indicating a stronger proven value proposition.

Both are cloud-based, FDA-cleared, HIPAA-compliant, and have BAAs. Viz.ai, however, demonstrates superior enterprise readiness with its extensive deployment across 2,000 hospitals, seamless integration with PACS and EHRs, and a broader array of security and privacy certifications including SOC 2 Type II and multiple ISO standards. Its integrated care coordination platform also supports a more holistic enterprise solution for acute care pathways.

EchoSolv AS innovates with its measurement-based AI for severe AS detection, notably by not using LVOT measurements and improving gender equity in diagnosis. Viz RV/LV's innovation is part of a broader platform that automates critical measurements for acute conditions and integrates them with real-time alerts, mobile imaging, and care coordination. Viz.ai's continuous development, including over 50 FDA-cleared algorithms and the new Viz Agent Studio for custom AI care pathways, demonstrates a more expansive and impactful innovation strategy across multiple disease states and workflow customization.

Viz.ai provides a clearly defined support structure, including 24/7/365 urgent phone support, email support, a comprehensive Help Center, and a dedicated customer success team, along with a transparent Trust Center for documentation. While EchoSolv AS mentions a user manual and Trust Center, the detailed commitment to round-the-clock support and extensive documentation resources is more explicitly demonstrated by Viz.ai.